Reduction of Peptide Character of HIV Protease Inhibitors That Exhibit Nanomolar Potency against Multidrug Resistant HIV-1 Strains
- 18 March 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (9) , 1764-1768
- https://doi.org/10.1021/jm020537i
Abstract
Novel HIV protease inhibitors containing a hydroxyethylamine dipeptide isostere as a transition state-mimic king structure were synthesized by combining substructures of known HIV protease inhibitors. Among them, TYA5 and TYB5 were proven to be not only potent enzyme inhibitors (Ki = 0.12 nM and 0.10 nM, respectively) but also strong anti-HIV agents (IC50 = 9.5 nM and 66 nM, respectively), even against viral strains with multidrug resistance. Furthermore, insertion of an (E)-alkene dipeptide isostere at the P1−P2 position of TYB5 led to development of a purely nonpeptidic protease inhibitor, TYB1 (Ki = 0.38 nM, IC50 = 160 nM).Keywords
This publication has 12 references indexed in Scilit:
- Synthesis and evaluation of pseudopeptide analogues of a specific CXCR4 inhibitor, T140: The insertion of an (E)-alkene dipeptide isostere into the βII′-turn moietyBioorganic & Medicinal Chemistry Letters, 2002
- A Potent Human Immunodeficiency Virus Type 1 Protease Inhibitor, UIC-94003 (TMC-126), and Selection of a Novel (A28S) Mutation in the Protease Active SiteJournal of Virology, 2002
- Structure−Activity Relationship of Small-Sized HIV Protease Inhibitors Containing AllophenylnorstatineJournal of Medicinal Chemistry, 1999
- Bactericidal Domain of Lactoferrin: Detection, Quantitation, and Characterization of Lactoferricin in Serum by SELDI Affinity Mass SpectrometryBiochemical and Biophysical Research Communications, 1998
- Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 ProteaseJournal of Medicinal Chemistry, 1997
- Potent Human Immunodeficiency Virus Type 1 Protease Inhibitors That Utilize Noncoded d-Amino Acids as P2/P3 LigandsJournal of Medicinal Chemistry, 1996
- Amino Diol HIV Protease Inhibitors. 1. Design, Synthesis, and Preliminary SARJournal of Medicinal Chemistry, 1994
- Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostereJournal of Medicinal Chemistry, 1993
- Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogs with varying side chains: the "iminoacridan hypothesis"Journal of Medicinal Chemistry, 1990
- Immunobiology and Pathogenesis of Hepatocellular Injury in Hepatitis B Virus Transgenic MiceScience, 1990